Article

Spinning Disk Platform for Microfluidic Digital Polymerase Chain Reaction

University of Utah, Rm 5R441, 1795 E South Campus Dr., Salt Lake City, Utah 84112, USA.
Analytical Chemistry (Impact Factor: 5.83). 02/2010; 82(4):1546-50. DOI: 10.1021/ac902398c
Source: PubMed

ABSTRACT An inexpensive plastic disk disposable was designed for digital polymerase chain reaction (PCR) applications with a microfluidic architecture that passively compartmentalizes a sample into 1000 nanoliter-sized wells by centrifugation. Well volumes of 33 nL were attained with a 16% volume coefficient of variation (CV). A rapid air thermocycler with aggregate real-time fluorescence detection was used, achieving PCR cycle times of 33 s and 94% PCR efficiency, with a melting curve to validate product specificity. A CCD camera acquired a fluorescent image of the disk following PCR, and the well intensity frequency distribution and Poisson distribution statistics were used to count the positive wells on the disk to determine the number of template molecules amplified. A 300 bp plasmid DNA product was amplified within the disk and analyzed in 50 min with 58-1000 wells containing plasmid template. Target concentrations measured by the spinning disk platform were 3 times less than that predicted by absorbance measurements. The spinning disk platform reduces disposable cost, instrument complexity, and thermocycling time compared to other current digital PCR platforms.

0 Followers
 · 
107 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rapid and timely diagnosis of infectious diseases is a critical determinant of clinical outcomes and general public health. For the detection of various pathogens, microfluidics-based platforms offer many advantages, including speed, cost, portability, high throughput, and automation. This review provides an overview of the recent advances in microfluidic technologies for point-of-care (POC) diagnostics for infectious diseases. The key aspects of such technologies for the development of a fully integrated POC platform are introduced, including sample preparation, on-chip nucleic acid analysis and immunoassay, and system integration/automation. The current challenges to practical implementation of this technology are discussed together with future perspectives. Copyright © 2014. Published by Elsevier B.V.
    Journal of Chromatography A 12/2014; 1377. DOI:10.1016/j.chroma.2014.12.041 · 4.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Droplet microfluidics may soon change the paradigm of performing chemical analyses and related instrumentation. It is not only the analysis scale and possibility for sensitivity improvement, reduced consumption of chemical and biological reagents, but also the vast increase of the speed in performing a variety of unit operations. At present the microfluidic platforms can reproducibly generate monodisperse droplet populations at kHz or higher rate with sizes suitable for high-throughput experiments, single cell or even single molecule analysis. In addition to being used as microreactors with sizes in the micro- to femtoliter range; droplet based systems have also been used to directly synthesize particles and encapsulate biological entities for biomedicine and biotechnology applications. The aim of this work is to review the various droplet microfluidics operations and applications for (bio) chemical assays described in the literature during the past few years.
    The Analyst 09/2014; 140(1). DOI:10.1039/C4AN01209G · 3.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Personalized medicine - healthcare based on individual genetic variation - has the potential to transform the way healthcare is delivered to patients. The promise of personalized medicine has been predicated on the predictive and diagnostic power of genomic and proteomic biomarkers. Biomarker screening may help improve health outcomes, for example, by identifying individuals' susceptibility to diseases and predicting how patients will respond to drugs. Microfluidic droplet technology offers an exciting opportunity to revolutionize the accessibility of personalized medicine. A framework for the role of droplet microfluidics in biomarker detection can be based on two main themes. Emulsion-based microdroplet platforms can provide new ways to measure and detect biomolecules. In addition, microdroplet platforms facilitate high-throughput screening of biomarkers. Meanwhile, surface-based droplet platforms provide an opportunity to develop miniaturized diagnostic systems. These platforms may function as portable benchtop environments that dramatically shorten the transition of a benchtop assay into a point-of-care format.
    Expert Review of Molecular Diagnostics 08/2014; DOI:10.1586/14737159.2014.945437 · 4.27 Impact Factor